Appoints Joel Jung as Interim CFO with $8k/month salary and 60k options

Renalytix plc

Interim CFO Joel Jung receives $8,000 monthly base salary under consulting agreement.
Option grant of 60,000 ordinary shares; 1/4 vest Aug 28, 2024, rest monthly over 9 months.
Exercise price equals closing price of ordinary shares on AIM on day before grant.
Options fully vest upon change in control; agreement terminable with 3 months' notice.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Joel R. Jung

Interim Chief Financial Officer

RNLXY · Renalytix plc

Effective: 2024-05-27
Filed: June 12, 2024, 7:59 PM ET

announcing the appointment, on May 27, 2024, of Joel R. Jung as Interim Chief Financial Officer of the Company in connection with O. James Sterling’s resignation from his position with the Company.

Departed

O. James Sterling

Chief Financial Officer

RNLXY · Renalytix plc

Successor: Joel R. Jung
Filed: June 12, 2024, 7:59 PM ET

announcing the appointment, on May 27, 2024, of Joel R. Jung as Interim Chief Financial Officer of the Company in connection with O. James Sterling’s resignation from his position with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joel R. Jung was appointed as Interim Chief Financial Officer at Renalytix plc.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

announcing the appointment, on May 27, 2024, of Joel R. Jung as Interim Chief Financial Officer of the Company in connection with O. James Sterling’s resignation from his position with the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

O. James Sterling resigned as Chief Financial Officer at Renalytix plc.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

announcing the appointment, on May 27, 2024, of Joel R. Jung as Interim Chief Financial Officer of the Company in connection with O. James Sterling’s resignation from his position with the Company.

View on SEC.gov

Renalytix plc filing history →

Source: SEC EDGAR

accession 0000950170-24-072531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.